Bank of New York Mellon’s Genelux GNLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-48,606
Closed -$313K 4189
2024
Q1
$313K Sell
48,606
-5,235
-10% -$47.5K ﹤0.01% 3759
2023
Q4
$754K Sell
53,841
-97
-0.2% -$1.53K ﹤0.01% 3338
2023
Q3
$1.32M Buy
53,938
+44,584
+477% +$1.13M ﹤0.01% 3016
2023
Q2
$306K Buy
+9,354
New +$263K ﹤0.01% 3821

Other funds holding GNLX

Bank of New York Mellon's GNLX Position: Q2 2024 in Review

Bank of New York Mellon sold out of Genelux (GNLX) in Q2 2024, closing a stake of 48,606 shares — an estimated $313K sold.

Bank of New York Mellon first reported a position in GNLX in Q2 2023 and held it in 4 quarters. The position peaked at $1.32M in Q3 2023. 73 funds tracked by Wall St. Rank hold GNLX as of Q2 2024.

  • Bank of New York Mellon reported no remaining Genelux position as of Q2 2024 after selling out during the quarter.
  • Bank of New York Mellon sold 48,606 Genelux shares in Q2 2024, an estimated $313K.
  • Bank of New York Mellon first reported a position in Genelux in Q2 2023 and held it in 4 quarters.
  • Bank of New York Mellon's Genelux position peaked at $1.32M in Q3 2023.
  • 73 funds tracked by Wall St. Rank held Genelux as of Q2 2024.

Based on Bank of New York Mellon's 13F filing for Q2 2024, filed 25 Jul 2024.